financetom
Business
financetom
/
Business
/
Novavax Says COVID-19 Vaccine Approval in Japan Triggers Takeda Milestone Payment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novavax Says COVID-19 Vaccine Approval in Japan Triggers Takeda Milestone Payment
Sep 4, 2025 5:58 AM

08:41 AM EDT, 09/04/2025 (MT Newswires) -- Novavax ( NVAX ) said Thursday that approval of its Nuvaxovid COVID-19 vaccine in Japan has triggered a milestone payment from Takeda Pharmaceutical ( TAK ) under the terms of its licensing agreement.

The company said it is eligible to receive royalties on net sales of Nuvaxovid from Takeda this vaccination season, and that a portion of the milestone payment can be credited towards future royalty payments.

Novavax ( NVAX ) said payment amounts from Takeda cannot be disclosed due to confidentiality agreements.

Novavax ( NVAX ) shares were 0.5% higher in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved